E-Scape Bio is developing a pipeline of ApoE4 structure correctors for the treatment of neurodegenerative diseases, including Alzheimer’s disease.
E-Scape Bio is developing a pipeline of ApoE4 structure correctors for the treatment of neurodegenerative diseases, including Alzheimer’s disease.
E-Scape Bio is developing a pipeline of ApoE4 structure correctors for the treatment of neurodegenerative diseases, including Alzheimer’s disease.